Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
설정
언어
한국어
통화
USD
테마
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
주식 순위 #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
주가
$0.25974701
마지막 동기화: 2025-01-06
시가총액
$2.04M
변동 (1일)
0.74%
변동 (1년)
0.00%
국가
FR
거래 Acticor Biotech SAS (ALACT)

카테고리

Healthcare
Acticor Biotech SAS (ALACT)의 주가 이력
최고 종가: $0.26 (2025-01-01 기준)

최저 종가: $7.56 (2021-11-01 기준)
Acticor Biotech SAS의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2025 -4.45%
2024 -91.43%
2023 -58.60%
2022 31.92%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.26 31.04%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $987.98 30.54%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.35 -10.30%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $142.87 498.26%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $697.62 1.32%
CH